New evidence-based guidelines for treating SSc

Nature Reviews Rheumatology

Volumn 5, Issue 6, 2009, Pages 300-302

  Pope, Janet E ^a  

^a Division of Rheumatology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; NOTE; PRACTICE GUIDELINE; RHEUMATOLOGY; SYSTEMIC SCLEROSIS;

EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC;

EID: 68849088743     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.98     Document Type: Short Survey

References (10)

1. Pope, J. E., Ouimet, J. & Krizova, A. scleroderma treatment differs between experts and general rheumatologists. Arthritis Rheum. 55, 138-145 (2006).
2. Kowal-Bielecka, O. et al. eULAR recommendations for the treatment of systemic sclerosis: a report from the eULAR scleroderma Trials and Research group (eUsTAR). Ann. Rheum. Dis. doi:10.1136/ard.2008.096677 (2009).
3. Thompson, A. E., shea, B., welch, V., Fenlon, D. & Pope, J. E. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis Rheum. 44, 1841-1847 (2001).
4. Pope, J. et al. iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database of Systematic Reviews 1998, issue 2. Art. no.:CD000953. doi:10.1002/14651858. CD000953 (2000).
5. Malefant, D., Catton, M. & Pope, J. The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis. Rheumatology (Oxford) (in press).
6. Johnson, S., Feldman, B., Pope, J. & Tomlinson, G. shifting our thinking about uncommon disease trials: the case of methotrexate in scleroderma. J. Rheumatol. 36, 323-329 (2009).
7. Pope, J. E. Musculoskeletal involvement in scleroderma. Rheum. Dis. Clin. North Am. 29, 391-408 (2003).
8. Hachulla, E. et al. early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 52, 3792-3800 (2005).
9. Pope, J. E. et al. The prevalence of pulmonary arterial hypertension in a large Canadian multicentre cohort of systemic sclerosis subjects. (PHAse study) [abstract]. J. Rheumatol. 31, 1440 (2004).
10. Villela, R. et al. Assessment of unmet needs in the design of randomized controlled trials and the lack of generalizability for scleroderma treatment. Arthritis Rheum. 59, 706-713 (2008).